Towards a better understanding of Kaposi sarcoma-associated immune reconstitution inflammatory syndrome

AIDS

Volumn 27, Issue 10, 2013, Pages 1667-1669

  Ablanedo Terrazas, Yuria ^a   De La Barrera, Claudia Alvarado ^a   Reyes Terán, Gustavo ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; PREDNISONE;

CD4 LYMPHOCYTE COUNT; CRYPTOCOCCOSIS; DISEASE ASSOCIATION; HERPES ZOSTER; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; MORTALITY; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHODGKIN LYMPHOMA; NOTE; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TUBERCULOSIS; VIRUS LOAD;

FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; SARCOMA, KAPOSI;

EID: 84879106490     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328360106b     Document Type: Note

References (19)

1. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000; 1:107-115.
2. Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 2007; 4:9.
3. Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:251-261.
4. Davies MA, Meintjes G. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis 2009; 49:973-975.
5. Lawn SD, Wood R. Immune reconstitution inflammatory syndrome. Lancet Infect Dis 2010; 10:833-834.
6. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, Worodria W, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8:516-523.
7. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: literature review and proposed clinical case definitions. Lancet Infect Dis 2010; 10:791-802.
8. Novak RM, Richardson JT, Buchacz K, Chmiel JS, Durham MD, Palella FJ, et al. Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 2012; 26:721-730.
9. Leidner RS, Aboulafia DM. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS 2005; 19:635-644.
10. Bower M, Nelson M, Young AM, Thirlwell C, Newsom-Davis T, Mandalia S, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005; 23:5224-5228.
11. Letang E, Almeida JM, Miró JM, Ayala E, White IE, Carrilho C, et al. Predictors of immune reconstitution inflammatory syndrome-associated with Kaposi sarcoma in Mozambique: a prospective study. J Acquir Immune Defic Syndr 2010; 53:589-597.
12. Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, et al. Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS 2013; 27:635-643.
13. Letang E, Naniche D, Bower M, Miro JM. Kaposi sarcoma-associated immune reconstitution inflammatory syndrome: in need of a specific case definition. Clin Infect Dis 2012; 55:157-158.
14. Letang E, Lewis JJ, Bower M, Mosam A, Borok M, Campbell TB, et al. Paradoxical immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and associated mortality in Africa than in the UK. AIDS 2013; 27:000-000.
15. Ramdial PK, Sing Y, Subrayan S, Calonje E, Aboobaker J, Sydney C, et al. Granulomas in acquired immunodeficiency syndrome-associated cutaneous Kaposi sarcoma: evidence for a role for Mycobacterium tuberculosis. J Cutan Pathol 2010; 37:827-834.
16. Hickman SP, Chan J, Salgame P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J Immunol 2002; 168:4636-4642.
17. Gill PS, Loureiro C, Bernstein-Singer M, Rarick MU, Sattler F, Levine AM. Clinical effect of glucocorticoids on Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:937-940.
18. Mbulaiteye S, Goedert J. Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa. AIDS 2008; 22:535-537.
19. Sitas F, Carrara H, Beral V, Newton R, Reeves G, Bull D, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340:1863-1871. Honorable Cámara de Diputados de la LXI Legislatura de Mexico)